endometriosis epidemiology forecast

DelveInsight's "Endometriosis - Epidemiology Forecast - 2034" report delivers an in-depth understanding of the endometriosis, historical and forecasted epidemiology as well as the endometriosis market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.

Geography Covered

• The United States
• EU4 (Germany, France, Italy, and Spain) and the United Kingdom
• Japan

Study Period: 2021-2034

Endometriosis Understanding

The DelveInsight’s Endometriosis epidemiology report gives a thorough understanding of the disease. Endometriosis is a disease distinguished by endometrial tissue outside the uterine cavity with recurrent intralesional bleeding because of the hormonal responsiveness of ectopic endometrial tissue, resulting in fibrosis. It is a disease of adolescents and reproductive-aged women commonly associated with chronic pelvic pain and infertility. The most common locations for endometriosis are the ovaries, pelvic peritoneum, uterosacral ligaments, and torus uterinus. Atypical pelvic endometriosis localizations can occur in the cervix, vagina, round ligaments, ureter, and nerves. Moreover, rare extrapelvic endometriosis implants can be localized in the upper abdomen, subphrenic fold, or abdominal wall.

The diagnosis of endometriosis has usually delayed an average of 4-11 years from the onset of symptoms due to the non-existence of a pathognomonic test or biomarker to detect the disease but also to the diversity of symptoms that could be considered physiologic responses during menstruation (like pain and discomfort) but also to the wide range of reported symptoms overlap with other gastrointestinal or gynecological causes. To achieve a proper diagnosis of endometriosis, the physician should start by taking a detailed history and performing a gynecological physical examination. The gold standard diagnostic tool remains laparoscopy, combined with an abdominal cavity exploration and a histological biopsy. However, ovarian endometrioma and deep nodular forms of the disease can be detected through ultrasonography and MRI.

Endometriosis Epidemiology

The epidemiology section provides insights about the historical and current endometriosis patient pool and forecasted trends for individual seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

Key Findings

The disease epidemiology covered in the report provides a historical as well as forecasted endometriosis epidemiology scenario in the 7MM covering the United States, EU4 countries and the United Kingdom, and Japan from 2021 to 2034.

In 2021, the total prevalent cases of endometriosis were ~ 21,920,000 in the 7MM, which are expected to grow during the study period, i.e., 2021-2034.

The disease epidemiology covered in the report provides historical as well as forecasted endometriosis epidemiology [segmented as Total Prevalent Cases of Endometriosis, Total Diagnosed Prevalent Cases of Endometriosis, Age-specific Diagnosed Prevalent Cases of Endometriosis, Diagnosed Prevalent Cases of Endometriosis by Pain Severity, and Total Treated Cases of Endometriosis] in the 7MM covering the United States, EU4 countries and the United Kingdom, and Japan from 2021 to 2034.

Country Wise- Endometriosis Epidemiology

The epidemiology segment also provides the endometriosis epidemiology data and findings across the United States, EU4 and the United Kingdom, and Japan.

KOL- Views

To keep up with the current endometriosis patient pool and forecasted trend, we take KOLs and SMEs' opinions working in the endometriosis domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate the patient pool and forecasted trend.

Scope of the Report

• The report covers the descriptive overview of endometriosis, explaining its causes, symptoms, and pathophysiology.
• The report provides insight into the 7MM historical and forecasted patient pool covering the United States, EU4 countries and the United Kingdom, and Japan.
• The report assesses the disease risk and burden and highlights the unmet needs of endometriosis.
• The report helps to recognize the growth opportunities in the 7MM concerning the patient population.
• The report provides the segmentation of the disease epidemiology for 7MM by Total Prevalent Cases of Endometriosis, Total Diagnosed Prevalent Cases of Endometriosis, Age-specific Diagnosed Prevalent Cases of Endometriosis, Diagnosed Prevalent Cases of Endometriosis by Pain Severity, and Total Treated Cases of Endometriosis in the 7MM covering the United States, EU4 countries and the United Kingdom, and Japan from 2021 to 2034

Report Highlights

• The companies and academics are working to assess challenges and seek opportunities that could influence endometriosis R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition.
• A better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for endometriosis.
• Our in-depth analysis of the pipeline assets across different stages of development (Phase III and Phase II), different emerging trends, and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities.

Endometriosis Report Key Strengths

• 11 Years Forecast
• 7MM Coverage
• Endometriosis Epidemiology Segmentation

Key Questions

Epidemiology Insights:

• What are the disease risk, burden, and regional/ethnic differences of endometriosis?
• What are the key factors driving the epidemiology trend for seven major markets covering the United States, EU4 and the United Kingdom, and Japan?
• What is the historical endometriosis patient pool in seven major markets covering the United States, EU4 and the United Kingdom, and Japan?
• What would be the forecasted patient pool of endometriosis in seven major markets covering the United States, EU4 and the United Kingdom, and Japan?
• Where will be the growth opportunities in the 7MM concerning the patient population about endometriosis?
• Out of all 7MM countries, which country would have the highest prevalent population of endometriosis during the forecast period (2025-2034)?
• At what CAGR the patient population is expected to grow by 7MM during the forecast period (2025-2034)?

Reasons to buy

• The report will help in developing business strategies by understanding trends shaping and driving the Endometriosis Disease market
• To understand the future market competition in the Endometriosis Disease market
• Organize sales and marketing efforts by identifying the best opportunities for Endometriosis Disease in the US, EU4 and the UK, and Japan
• Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
• Organize sales and marketing efforts by identifying the best opportunities for the Endometriosis Disease market
• To understand the future market competition in the Endometriosis Disease market